The Effect of Perioperative Topical Ketorolac 0.5% on Macular Thickness after Uneventful Phacoemulsification

Table 1

Demographical data of patients.

	Group 1 ()	Group 2 ()	value
Male (%)/female (%)	13(59.1%)/9(40.9%)	14(66.7%)/7 (33.3%)	0.402
Age (years)	62.9 ± 10.9	67.4 ± 10.3	0.181
EPT (sec)	10.7 ± 8.8	13.5 ± 11.3	0.544
Phacoenergy (%)	17.0 ± 7.8	15.8 ± 10.1	0.679

Group 1: ketorolac/steroid group; group 2: steroid group; EPT: effective phaco time. (Mann–Whitney U test, ).